These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 7612733

  • 1. Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPD.
    Zemel D, Betjes MG, Dinkla C, Struijk DG, Krediet RT.
    Perit Dial Int; 1995; 15(2):134-41. PubMed ID: 7612733
    [Abstract] [Full Text] [Related]

  • 2. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D, Koomen GC, Hart AA, ten Berge IJ, Struijk DG, Krediet RT.
    J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688
    [Abstract] [Full Text] [Related]

  • 3. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D, Struijk DG, Dinkla C, Stolk LM, ten Berge IJ, Krediet RT.
    J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393
    [Abstract] [Full Text] [Related]

  • 4. Are phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis?
    Douma CE, de Waart DR, Struijk DG, Krediet RT.
    J Lab Clin Med; 1998 Oct; 132(4):329-40. PubMed ID: 9794705
    [Abstract] [Full Text] [Related]

  • 5. Changes in water transport across the peritoneum during treatment with continuous ambulatory peritoneal dialysis in selected patients with and without peritonitis.
    Radtke M, Albrektsen GE, Widerøe TE, Nilsen TI, Romundstad P, Hallan S, Aasarød K, Laegreid IK, Oien C.
    Perit Dial Int; 2004 Oct; 24(6):571-9. PubMed ID: 15559487
    [Abstract] [Full Text] [Related]

  • 6. Prostaglandin-mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysis.
    Steinhauer HB, Schollmeyer P.
    Kidney Int; 1986 Feb; 29(2):584-90. PubMed ID: 3457982
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammation.
    Zemel D, Krediet RT, Koomen GC, Kortekaas WM, Geertzen HG, ten Berge RJ.
    Nephrol Dial Transplant; 1994 Feb; 9(2):169-74. PubMed ID: 8190331
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-6 in CAPD patients without peritonitis: relationship to the intrinsic permeability of the peritoneal membrane.
    Zemel D, ten Berge RJ, Struijk DG, Bloemena E, Koomen GC, Krediet RT.
    Clin Nephrol; 1992 Feb; 37(2):97-103. PubMed ID: 1551256
    [Abstract] [Full Text] [Related]

  • 9. Day-to-day variability of protein transport used as a method for analyzing peritoneal permeability in CAPD.
    Zemel D, Krediet RT, Koomen GC, Struijk DG, Arisz L.
    Perit Dial Int; 1991 Feb; 11(3):217-23. PubMed ID: 1716996
    [Abstract] [Full Text] [Related]

  • 10. Intraperitoneal interleukin-8 and neutrophil influx in the initial phase of a CAPD peritonitis.
    Betjes MG, Visser CE, Zemel D, Tuk CW, Struijk DG, Krediet RT, Arisz L, Beelen RH.
    Perit Dial Int; 1996 Feb; 16(4):385-92. PubMed ID: 8863332
    [Abstract] [Full Text] [Related]

  • 11. Prostaglandin inhibition by intraperitoneal indomethacin has no effect on peritoneal permeability during stable CAPD.
    Douma CE, de Waart DR, Zemel D, Struijk DG, Krediet RT.
    Nephrol Dial Transplant; 2001 Apr; 16(4):803-8. PubMed ID: 11274278
    [Abstract] [Full Text] [Related]

  • 12. Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?
    Cueto-Manzano AM, Rojas-Campos E, Martínez-Ramírez HR, Valera-González I, Medina M, Monteón F, Ruiz N, Becerra M, Palomeque MA, Cortés-Sanabria L.
    Perit Dial Int; 2006 Apr; 26(3):341-8. PubMed ID: 16722027
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.
    Brauner A, Hylander B, Wretlind B.
    Am J Kidney Dis; 1996 Mar; 27(3):402-8. PubMed ID: 8604710
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Choi KC, Jeong TK, Lee SC, Kim SW, Kim NH, Lee KY.
    Adv Perit Dial; 1998 Mar; 14():173-9. PubMed ID: 10649719
    [Abstract] [Full Text] [Related]

  • 17. Effect of indomethacin on peritoneal protein loss in a rabbit model of peritonitis.
    Peng H, Cheung AK, Reimer LG, Kamerath CD, Leypoldt JK.
    Kidney Int; 2001 Jan; 59(1):44-51. PubMed ID: 11135056
    [Abstract] [Full Text] [Related]

  • 18. Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD.
    Pannekeet MM, Zemel D, Koomen GC, Struijk DG, Krediet RT.
    Perit Dial Int; 1995 Jan; 15(6):217-25. PubMed ID: 7578497
    [Abstract] [Full Text] [Related]

  • 19. Impaired initial cell reaction in CAPD-related peritonitis.
    Koopmans JG, Boeschoten EW, Pannekeet MM, Betjes MG, Zemel D, Kuijper EJ, Krediet RT.
    Perit Dial Int; 1996 Jan; 16 Suppl 1():S362-7. PubMed ID: 8728224
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-8 in chronic renal failure and dialysis patients.
    Nakanishi I, Moutabarrik A, Okada N, Kitamura E, Hayashi A, Syouji T, Namiki M, Ishibashi M, Zaid D, Tsubakihara Y.
    Nephrol Dial Transplant; 1994 Jan; 9(10):1435-42. PubMed ID: 7816257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.